Home › NDC Lookup › RxCUI directory › RxCUI 608796

Omeprazole 20 MG Delayed Release Oral Tablet [Prilosec] — RxCUI 608796

RxNorm drug concept · Semantic branded drug
RxCUI 608796 Semantic branded drug · SBD ● Current RxNorm concept 4 FDA products 14 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI608796
Official nameOmeprazole 20 MG Delayed Release Oral Tablet [Prilosec]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asPrilosec OTC 20 MG Delayed Release Oral Tablet; Prilosec 20 MG (as omeprazole magnesium 20.6 MG) Delayed Release Oral Tablet
FDA products mapped4
Package NDCs mapped14
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Omeprazole: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Omeprazole turns down your stomach's acid production by blocking the pump that makes acid in the first place. Depending on why you're taking it, that can mean relief from heartburn...
  • What exactly is omeprazole supposed to do for me?
  • Take it about 30 minutes before a meal, ideally before breakfast. Taking it before eating gives it the best chance to be absorbed and ready to work when your stomach starts produci...
  • When should I take it — before or after eating?
📖 Read our full Omeprazole guide →

🕸️ Concept Web — How Omeprazole 20 MG Delayed Release Oral Tablet [Pr... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Omeprazole 20 MG Delayed Release Oral Tablet [Prilosec] RxCUI 608796

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Omeprazole 7646
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Prilosec 203345
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Omeprazole Delayed Release Oral Tablet 402424
    • Omeprazole Oral Product 1161028
    • Omeprazole Pill 1161029
    • Omeprazole Delayed Release Oral Tablet [Prilosec] 608795
    • Prilosec Oral Product 1178238
    • Prilosec Pill 1178239
    • Delayed Release Oral Tablet 10312
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Omeprazole 20 MG [Prilosec] SBDC · 541245
  • Omeprazole Delayed Release Oral Tablet [Prilosec] SBDF · 608795
  • Prilosec Oral Product SBDG · 1178238
  • Prilosec Pill SBDG · 1178239
  • Prilosec BN · 203345

📦 FDA Products & Package NDCs

4 products · 14 package NDCs
14 package NDCs map to RxCUI 608796 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
37000-0455-01 1 TABLET, DELAYED RELEASE in 1 POUCH (37000-455-01) Prilosec OTC The Procter & Gamble Manufacturing Company 2003-07-14
37000-0455-02 1 BLISTER PACK in 1 CARTON (37000-455-02) / 14 TABLET, DELA... Prilosec OTC The Procter & Gamble Manufacturing Company 2003-07-14
37000-0455-03 2 CARTON in 1 CARTON (37000-455-03) / 1 BLISTER PACK in 1 C... Prilosec OTC The Procter & Gamble Manufacturing Company 2003-07-14
37000-0455-04 3 CARTON in 1 CARTON (37000-455-04) / 1 BLISTER PACK in 1 C... Prilosec OTC The Procter & Gamble Manufacturing Company 2003-07-14
37000-0455-05 1 TABLET, DELAYED RELEASE in 1 BLISTER PACK (37000-455-05) Prilosec OTC The Procter & Gamble Manufacturing Company 2003-07-14
37000-0459-01 1 TABLET, DELAYED RELEASE in 1 POUCH (37000-459-01) Prilosec OTC The Procter & Gamble Manufacturing Company 2012-08-15
37000-0459-02 14 BLISTER PACK in 1 CARTON (37000-459-02) / 1 TABLET, DELA... Prilosec OTC The Procter & Gamble Manufacturing Company 2012-08-15
37000-0459-04 3 CARTON in 1 CARTON (37000-459-04) / 14 BLISTER PACK in 1... Prilosec OTC The Procter & Gamble Manufacturing Company 2012-08-15
37000-0459-05 1 TABLET, DELAYED RELEASE in 1 BLISTER PACK (37000-459-05) Prilosec OTC The Procter & Gamble Manufacturing Company 2012-08-15
84126-0300-14 1 BLISTER PACK in 1 CARTON (84126-300-14) / 14 TABLET, DELA... Prilosec OTC The Procter & Gamble Manufacturing Company 2025-09-01
84126-0300-24 2 BLISTER PACK in 1 CARTON (84126-300-24) / 14 TABLET, DELA... Prilosec OTC The Procter & Gamble Manufacturing Company 2025-09-01
84126-0300-42 3 BLISTER PACK in 1 CARTON (84126-300-42) / 14 TABLET, DELA... Prilosec OTC The Procter & Gamble Manufacturing Company 2025-09-01
84126-0301-14 1 BLISTER PACK in 1 CARTON (84126-301-14) / 14 TABLET, DELA... Prilosec OTC The Procter & Gamble Manufacturing Company 2025-06-03
84126-0301-42 3 BLISTER PACK in 1 CARTON (84126-301-42) / 14 TABLET, DELA... Prilosec OTC The Procter & Gamble Manufacturing Company 2025-06-03
Observed labelers: The Procter & Gamble Manufacturing Company (14) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.